Abstract
Progressive accumulation of cholesterol in the arterial wall causes atherosclerosis, the pathologic process underlying most heart attacks and strokes. Low density lipoprotein (LDL), the major carrier of blood cholesterol, has been implicated in the buildup of cholesterol in atherosclerotic plaques. Endothelial cells that line arteries function to transport LDL into the vessel wall. Models for the mechanism of cholesterol accumulation in atherosclerotic plaques emphasize increased LDL uptake into the vessel wall or increased retention of LDL that has entered the vessel wall. This article reviews the pathways of cholesterol entry and removal, the metabolism, and the physical changes of cholesterol in the vessel wall. How these processes are believed to contribute to cholesterol buildup in atherosclerotic plaques is discussed.
Keywords: Lipoprotein Cholesterol, Atherosclerosis, LDL particle, Phospholipid (PL), Unesterified cholesterol (UC), UC-rich Liposomes, neuraminidase
Current Molecular Medicine
Title: Lipoprotein Cholesterol and Atherosclerosis
Volume: 1 Issue: 6
Author(s): Howard S. Kruth
Affiliation:
Keywords: Lipoprotein Cholesterol, Atherosclerosis, LDL particle, Phospholipid (PL), Unesterified cholesterol (UC), UC-rich Liposomes, neuraminidase
Abstract: Progressive accumulation of cholesterol in the arterial wall causes atherosclerosis, the pathologic process underlying most heart attacks and strokes. Low density lipoprotein (LDL), the major carrier of blood cholesterol, has been implicated in the buildup of cholesterol in atherosclerotic plaques. Endothelial cells that line arteries function to transport LDL into the vessel wall. Models for the mechanism of cholesterol accumulation in atherosclerotic plaques emphasize increased LDL uptake into the vessel wall or increased retention of LDL that has entered the vessel wall. This article reviews the pathways of cholesterol entry and removal, the metabolism, and the physical changes of cholesterol in the vessel wall. How these processes are believed to contribute to cholesterol buildup in atherosclerotic plaques is discussed.
Export Options
About this article
Cite this article as:
Kruth S. Howard, Lipoprotein Cholesterol and Atherosclerosis, Current Molecular Medicine 2001; 1 (6) . https://dx.doi.org/10.2174/1566524013363212
DOI https://dx.doi.org/10.2174/1566524013363212 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy
Current Cancer Drug Targets GPE and GPE Analogues as Promising Neuroprotective Agents
Mini-Reviews in Medicinal Chemistry Synthesis of Natural and/or Biologically Relevant Three-membered Heterocycles and Derivatives through Asymmetric Epoxidation, Aziridination, Azirination and Thiirination
Letters in Organic Chemistry Lovastatin Reduces Apoptosis and Downregulates the CD40 Expression Induced by TNF-α in Cerebral Vascular Endothelial Cells
Current Neurovascular Research Why Image the Pancreatic Beta Cell?
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Mesenchymal Stem Cell Therapy for Patients with Ischemic Heart Failure- Past, Present, and Future
Current Stem Cell Research & Therapy Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Microfluidic Control of Hypoxia Aids Investigations of Islet Pathophysiology
Micro and Nanosystems L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in more Anti-Inflammatory HDL in Mice
Drug Metabolism Letters Hypercholesterolemia and Endothelium Dysfunction: Role of Dietary Supplementation as Vascular Protective Agents
Current Vascular Pharmacology Drug Eluting Stents in Interventional Cardiology - Current Evidence and Emerging Uses
Current Drug Targets - Cardiovascular & Hematological Disorders Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) Studies on Solubility Enhancement of Poorly Soluble NSAID Using Dual Approach of Micro-environmental pH Modulation and Melt Granulation
Current Drug Delivery Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research Hydroxytyrosol Promotes Superoxide Production and Defects in Autophagy Leading to Anti-proliferation and Apoptosis on Human Prostate Cancer Cells
Current Cancer Drug Targets Preparing India to Leverage Power of Mobile Technology: Development of a Bilingual Mobile Health Tool for Heart Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry The GSTM1 and GSTT1 Null Genotypes Increase the Risk for Type 2 Diabetes Mellitus and the Subsequent Development of Diabetic Complications: A Meta-analysis
Current Diabetes Reviews Leukocytes in Diabetic Retinopathy
Current Diabetes Reviews Plasma Retinol Binding Protein 4 as a Biomarker for Detecting Progressive Stroke and Prediction of Early Prognosis in Patients with Acute Ischemic Stroke
Current Neurovascular Research MAPK: A Key Player in the Development and Progression of Stroke
CNS & Neurological Disorders - Drug Targets